Cutaneous Infections of the Patients with Malignancy

키워드

참고문헌 (37)

1. Kocarnik JM, "Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019 : a systematic analysis for the global burden of disease study 2019", JAMA Oncol, 8, pp.420~444 (2022)
2. Bow EJ, "Infection risk and cancer chemotherapy : the impact of the chemotherapeutic regimen in patients with lymphoma and solid tissue malignancies", J Antimicrob Chemother, 41(Suppl D), pp.1~5 (1998)
3. Rihana N, "Infections in Neutropenic Cancer Patients", pp.49~71 (2019), Springer International Publishing
4. Cornely OA, "Improving outcome of fungal diseases-Guiding experts and patients towards excellence", Mycoses, 60, pp.420~425 (2017)
5. Jenks JD, "Breakthrough invasive fungal infections : Who is at risk?", Mycoses, 63, pp.1021~1032 (2020)
6. Maschmeyer G, "Our 2014 approach to breakthrough invasive fungal infections", Mycoses, 57, pp.645~651 (2014)
7. Perlin DS, "The global problem of antifungal resistance : prevalence, mechanisms, and management", Lancet Infect Dis, 17, pp.e383~e392 (2017)
8. James C, "Herpes simplex virus : global infection prevalence and incidence estimates, 2016", Bull World Health Organ, 98, pp.315~329 (2020)
9. Tayyar R, "Herpes simplex virus and varicella zoster virus infections in cancer patients", Viruses, 15, pp.439~ (2023)
10. Hong J, "Strong association between herpes simplex virus-1 and chemotherapy-induced oral mucositis in patients with hematologic malignancies", Korean J Intern Med, 35, pp.1188~1198 (2020)
11. Jalouli J, "Human papilloma virus, herpes simplex virus and epstein barr virus in oral squamous cell carcinoma from eight different countries", Anticancer Res, 32, pp.571~580 (2012)
12. Forman SJ, "Thomas'hematopoietic cell transplantation: stem cell transplantation" (2015), John Wiley & Sons
13. Schuchter LM, "Herpes zoster infection after autologous bone marrow transplantation", Blood, 74, pp.1424~1427 (1989)
14. Erard V, "One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation : no evidence of rebound varicella-zoster virus disease after drug discontinuation", Blood, 110, pp.3071~3077 (2007)
15. McKay SL, "Herpes zoster risk in immunocompromised adults in the United States : A Systematic Review", Clin Infect Dis, 71, pp.e125~e134 (2020)
16. Kim ST, "Varicella zoster virus infection during chemotherapy in solid cancer patients", Oncology, 82, pp.126~130 (2012)
17. Drozd B, "Cutaneous cytomegalovirus manifestations, diagnosis, and treatment : a review", Dermatol Online J, 25, pp.13030~ (2019)
18. Tay MR, "Cytomegalovirus infection and end-organ disease in Asian patients with lymphoma receiving chemotherapy", Leuk Lymphoma, 55, pp.182~187 (2014)
19. Gunderson CG, "A systematic review of bacteremias in cellulitis and erysipelas", J Infect, 64, pp.148~155 (2012)
20. Khan T, "Streptococcus pneumoniae soft tissue infections in human immunodeficiency virus", Am J Med Sci, 342, pp.235~238 (2011)
21. Vuichard D, "Bullous cellulitis with Cryptococcus neoformans", Infection, 39, pp.181~182 (2011)
22. Ichiyama S, "Campylobacter fetus subspecies fetus cellulitis associated with bacteremia in debilitated hosts", Clin Infect Dis, 27, pp.252~255 (1998)
23. Bonner MJ, "Primary cellulitis due to Serratia marcescens", JAMA, 250, pp.2348~2349 (1983)
24. Raff AB, "Cellulitis : A Review", JAMA, 316, pp.325~337 (2016)
25. Stevens DL, "Practice guidelines for the diagnosis and management of skin and soft tissue infections : 2014 update by the Infectious Diseases Society of America", Clin Infect Dis, 59, pp.e10~e52 (2014)
26. Bodey GP, "Infections caused by Pseudomonas aeruginosa", Rev Infect Dis, 5, pp.279~313 (1983)
27. Grossman ME, "Cutaneous manifestations of infection in the immunocompromised host" (2012), Springer Science & Business Media
28. Arendorf TM, "The prevalence and intra-oral distribution of Candida albicans in man", Arch Oral Biol, 25, pp.1~10 (1980)
29. Horn DL, "Epidemiology and outcomes of candidemia in 2019 patients : data from the prospective antifungal therapy alliance registry", Clin Infect Dis, 48, pp.1695~1703 (2009)
30. Marr KA, "Invasive Candida infections : the changing epidemiology", Oncology(Williston Park), 18, pp.9~14 (2004)
31. Taudorf EH, "Cutaneous candidiasis-an evidence-based review of topical and systemic treatments to inform clinical practice", J Eur Acad Dermatol Venereol, 33, pp.1863~1873 (2019)
32. Boutati EI, "Fusarium, a significant emerging pathogen in patients with hematologic malignancy : ten years' experience at a cancer center and implications for management", Blood, 90, pp.999~1008 (1997)
33. Khatri AM, "Breakthrough invasive fungal infections on isavuconazole prophylaxis in hematologic malignancy &hematopoietic stem cell transplant patients", Transpl Infect Dis, 25(Suppl 1), pp.e1416~ (2023)
34. Petrikkos G, "Epidemiology and clinical manifestations of mucormycosis", Clin Infect Dis, 54(Suppl 1), pp.S23~S34 (2012)
35. Ibrahim AS, "Pathogenesis of mucormycosis", Clin Infect Dis, 54(Suppl 1), pp.S16~S22 (2012)
36. Cornely OA, "Global guideline for the diagnosis and management of mucormycosis : an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium", Lancet Infect Dis, 19, pp.e405~e421 (2019)
37. Fishman JA, "Infection in organ transplantation", Am J Transplant, 17, pp.856~879 (2017)

관련 논문AI추천